Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Off-Label Use of Atypical Antipsychotics: An Update

Slide: 36 of 47

Summary of Adverse Effects in Elderly Patients (1 of 2)

Antipsychotics increase the risk of death in elderly patients (65 and older) with dementia.

For atypical antipsychotics, the death of 1 in 100 patients can be attributed to the antipsychotic drug. The strength of evidence for this finding is high.

Risperidone is associated with an increased risk of cerebrovascular accidents. One in 34 patients will experience a cerebrovascular accident attributable to risperidone. The strength of evidence for this finding is moderate.

Both risperidone and olanzapine are associated with increased risk of cardiovascular adverse events. For every 53 patients treated, 1 cardiovascular adverse event will occur due to risperidone. For every 48 patients treated, 1 cardiovascular adverse event will occur due to olanzapine. The strength of evidence for these findings is moderate.